CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
Us Concrete Inc  (USCR)
Other Ticker:  
 
 
Price: $44.9900 $0.51 1.147%
Day's High: $45.68 Week Perf: 0.02 %
Day's Low: $ 44.35 30 Day Perf: 5.29 %
Volume (M): 200 52 Wk High: $ 65.85
Volume (M$): $ 8,985 52 Wk Avg: $45.30
Open: $44.41 52 Wk Low: $27.68



 Market Capitalization (Millions $) 748
 Shares Outstanding (Millions) 17
 Employees 643
 Revenues (TTM) (Millions $) 1,506
 Net Income (TTM) (Millions $) 31
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 40

Us Concrete Inc
We are a leading producer of ready-mixed concrete in select geographic markets in the United States. We operate our business through two primary segments: ready-mixed concrete and aggregate products. Ready-mixed concrete is one of the most versatile and widely used materials in construction. This important building material is used in the vast majority of commercial, residential and public works construction projects. Aggregates are granular raw materials essential in the production of ready-mixed concrete.


USCR is expected to report next financial results on May 06, 2019.
 

Us Concrete Inc's Segments
 
 
  Company Estimates  
  Revenue Outlook
Us Concrete Inc does not provide revenue guidance.

Earnings Outlook
Us Concrete Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion

Pressure Biosciences Inc

Company Fail to Break-even Despite Surge in Sales

Company increased losses at $-2.83 per share in the forth quarter, although it's Sales surged by 36.57 % to $0.69 millions from the same quarter a year ago.

Adamant Dri Processing & Minerals Group

Adamant Dri Processing & Minerals Group announced forth quarter operating income of $2.365358 millions

In the forth quarter Adamant Dri Processing & Minerals Group earnings turn positive of $0.41 per share compare to $-0.05 a year ago and from $0.00 per share from the previous quarter.

Sales fell sharply by -95.82 % to $0.05 millions from $1.17 millions in the same quarter a year ago and sequentially from $0.00 millions.

Respirerx Pharmaceuticals Inc.

Respirerx Pharmaceuticals Inc announced forth quarter operating shortfall of $-0.573603 millions

In the forth quarter Respirerx Pharmaceuticals Inc decreased loss of $-0.15 per share compare to $-0.27 a year ago and improved from $-0.16 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Immune Therapeutics, Inc.

Sales and Earnings Unchanged

In the forth quarter Immune Therapeutics, Inc reached break-even of $-0.00 per share compare to $-0.01 a year ago and from $-0.01 per share from the previous quarter.

Sales remained unchanged to $0.05 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Adhera Therapeutics, Inc.

Turn into Profitability, Revenues Unchanged

In the forth quarter Adhera Therapeutics, Inc turn a round at $0.37 per share, compare to results of $-0.01 per share a year ago quarter, In the previous quarter company realized $-0.69 per share.






Customers recorded net loss Customers recorded net loss
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


You need to upgrade your Flash Player

   
Major Competitors Stock performance

5 Days Decrease / Increase
     
EXP        6.43% 
VMC        1.92% 
USLM        4.08% 
SUM        7.06% 
SMID        1.8% 
GVA        5.33% 
• View Complete Report
   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SUME's Profile

Stock Price

SUME's Financials

Business Description

Fundamentals

Charts & Quotes

SUME's News

Suppliers

SUME's Competitors

Customers & Markets

Economic Indicators

SUME's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071